Rx-360 2023 Board of Directors Ballot


Manufacturer (Tier 1 and Tier 2). Please select up to six nominees.
Supplier (Tier 4). Please select up to four nominees.

Learn more about the candidates below.

Bill Campagna: Eli Lilly and Co. – CV LOI
Sr. Director – QA – Global Quality Auditing and Compliance

Tom Lupo: Bayer – CV LOI
Global Head of Quality Audits and Inspections

Anthony Damas: Johnson & Johnson – CV LOI
Vice President of Enterprise Regulatory Compliance

Christy Mocny: Biogen – CV LOI
Director, Corporate Quality Audits and Compliance

Robert Smith: GlaxoSmithKline – CV LOI
Supplier Quality Audit & Compliance Hub Head NALA / Reg. Director EUNALAMEA / SQAC Head NALA

Rebecca Alcantara: Curia Global – CV LOI
Director, Global Supplier Quality and Compliance

Christian Liebl: Schreiner MediPharm – CV LOI
Senior Innovations & Process Manager

Isabelle Quintard: Sartorius – LOI
Head of BPS Quality System Compliance

Stephan Peeters: Lonza – CV LOI
Global Quality Lead Supply Chain Projects (Executive Director QA)

Kathleen Silva: MilliporeSigma – CV LOI
Head of Quality Management Systems and Audits